汇宇制药(688553) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥242,604,188.27, representing a year-on-year increase of 2.05%[4] - The net profit attributable to shareholders was ¥46,435,905.16, reflecting a significant increase of 20.94% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses surged by 110.53% to ¥37,514,613.03[4] - The basic and diluted earnings per share both stood at ¥0.11, marking a 20.95% increase year-on-year[4] - Total operating revenue for Q1 2024 was ¥242,604,188.27, an increase of 2.4% compared to ¥237,720,069.60 in Q1 2023[15] - Net profit for Q1 2024 was ¥44,879,334.61, up 16.3% from ¥38,395,308.10 in Q1 2023[16] - Earnings per share for Q1 2024 increased to ¥0.11, compared to ¥0.09 in Q1 2023[17] - The total comprehensive income for Q1 2024 was ¥44,948,732.88, compared to ¥38,456,769.97 in Q1 2023, reflecting an increase of 16.4%[17] Assets and Liabilities - The company's total assets increased by 2.63% to ¥4,808,881,819.76 compared to the end of the previous year[5] - As of March 31, 2024, the total assets of the company amounted to RMB 4,808,881,819.76, an increase from RMB 4,685,645,273.96 as of December 31, 2023, reflecting a growth of approximately 2.65%[12] - The company's current assets totaled RMB 2,971,856,903.97, up from RMB 2,870,156,288.20, indicating an increase of about 3.8%[12] - The company's total liabilities were RMB 989,509,625.27, an increase from RMB 911,221,812.34, marking a rise of around 8.6%[13] - The short-term borrowings increased to RMB 562,314,511.12 from RMB 426,732,400.71, reflecting a significant increase of approximately 31.7%[13] - The company's non-current assets totaled RMB 1,837,024,915.79, slightly up from RMB 1,815,488,985.76, indicating a growth of approximately 1.2%[12] - The company's equity remained stable at RMB 3,819,372,194.49, unchanged from the previous reporting period[13] Cash Flow and Investments - The net cash flow from operating activities was reported at ¥13,438,049.99, with no applicable year-on-year comparison[4] - Cash inflow from operating activities rose to ¥305,376,969.17 in Q1 2024, compared to ¥237,486,856.73 in Q1 2023, marking a growth of 28.6%[19] - The net cash flow from operating activities for Q1 2024 was $13,438,049.99, a significant improvement compared to a net outflow of $55,773,582.18 in Q1 2023[20] - Total cash inflow from investment activities was $420,350,601.27, down from $1,468,048,166.06 in the previous year, indicating a decrease of approximately 71.4%[20] - The net cash flow from investment activities for Q1 2024 was $39,578,048.79, recovering from a net outflow of $13,408,276.21 in Q1 2023[20] - Cash inflow from financing activities totaled $268,781,611.11, compared to $114,500,000.00 in the same quarter last year, representing an increase of approximately 134%[20] - The net cash flow from financing activities was $131,884,679.85, up from $114,180,534.03 in Q1 2023, showing a growth of about 15.5%[20] - The ending balance of cash and cash equivalents as of Q1 2024 was $1,814,964,936.81, an increase from $1,250,847,149.19 at the end of Q1 2023, reflecting a growth of approximately 45%[21] - Total cash and cash equivalents increased by $184,900,778.63 in Q1 2024, compared to an increase of $44,998,675.64 in Q1 2023, indicating a substantial improvement in liquidity[20] Research and Development - Research and development expenses totaled ¥67,248,405.84, which is a decrease of 20.07% year-on-year[4] - The proportion of R&D expenses to operating revenue was 27.72%, down by 7.67 percentage points from the previous year[5] - Research and development expenses decreased to ¥65,507,169.10 in Q1 2024 from ¥84,139,195.36 in Q1 2023, a decline of 22.2%[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,551[9] - The company's minority interest loss was ¥1,556,570.55 in Q1 2024, with no prior year comparison available[16] Employee Compensation and Tax - The company paid $78,046,471.47 in cash to employees in Q1 2024, down from $91,160,295.69 in the same period last year, a decrease of about 14.4%[20] - Tax payments increased to $31,925,712.64 in Q1 2024 from $12,312,412.29 in Q1 2023, representing a significant rise of approximately 159%[20]